# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst Felix Boeschen reinstates RXO (NYSE:RXO) with a Market Perform.
Stephens & Co. analyst Daniel Imbro reiterates RXO (NYSE:RXO) with a Equal-Weight and maintains $22 price target.
RXO (NYSE:RXO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percen...
Benchmark analyst Christopher Kuhn reiterates RXO (NYSE:RXO) with a Hold.
Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and raises the price target from $15 to $16.